Dachaigh › Lymphoma Cealla B Mòr Sgaoilte › Utah › Salt Lake City
Sgrùdaidhean clionaigeach Lymphoma Cealla B Mòr Sgaoilte ann an Salt Lake City, UT
Tha 12 sgrùdaidhean airson Lymphoma Cealla B Mòr Sgaoilte a’ lorg phàirtichean aig làraichean ann agus timcheall air Salt Lake City (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
A’ fastadhÌre 2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
- Intermountain Health LDS Hospital, Salt Lake City
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
A’ fastadhÌre 1
- Intermountain Healthcare, Salt Lake City
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
A’ fastadhÌre 1/2
- Intermountain - Primary Children's Hospital ( Site 1014), Salt Lake City
Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies
A’ fastadhÌre 1
- Huntsman Cancer Institute, Salt Lake City
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
A’ fastadhÌre 1/2
- Huntsman Cancer Institute, Salt Lake City
- Intermountain Healthcare, Salt Lake City
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
A’ fastadhÌre 3
- Intermountain Healthcare, Salt Lake City
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
A’ fastadhÌre 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
External Beam Radiotherapy Followed by Bispecific Antibody Therapy for Relapsed/Refractory DLBCL
A’ fastadhÌre 1
- Huntsman Cancer Institute at University of Utah, Salt Lake City
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
A’ fastadhÌre 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
A’ fastadhÌre 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
A’ fastadhÌre 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
A’ fastadhÌre 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Sgrùdaidhean Lymphoma Cealla B Mòr Sgaoilte ann am bailtean eile
- New York City, NY21 sgrùdaidhean
- Baldwin Park, CA19 sgrùdaidhean
- Chicago, IL18 sgrùdaidhean
- Houston, TX17 sgrùdaidhean
- Los Angeles, CA17 sgrùdaidhean
- Boston, MA16 sgrùdaidhean
- Milwaukee, WI16 sgrùdaidhean
- Nashville, TN15 sgrùdaidhean
- Portland, OR15 sgrùdaidhean
- Philadelphia, PA15 sgrùdaidhean
- Durham, NC14 sgrùdaidhean
- Dallas, TX13 sgrùdaidhean
Sgrùdaidhean eile ann an Salt Lake City
- Aillse Sgamhain Neo-chealla-beag31 sgrùdaidhean
- Aillse (gach seòrsa)27 sgrùdaidhean
- Aillse a' bhroilleach27 sgrùdaidhean
- Aillse colorectal21 sgrùdaidhean
- Ailseachadh nan Sgamhan21 sgrùdaidhean
- Myeloma iomaill21 sgrùdaidhean
- Melanoma21 sgrùdaidhean
- Ailse metastatach20 sgrùdaidhean
- Cancer Ovarian19 sgrùdaidhean
- Obesity18 sgrùdaidhean
- Leukemia myeloid geur17 sgrùdaidhean
- Fàilligeadh a' Chridhe17 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.